Skip to main content

Table 1 Clinicopathological characteristics between NOSES and laparoscopy-assisted surgery (Mini-Lapa)

From: A nomogram for predicting feasibility of laparoscopic anterior resection with trans-rectal specimen extraction (NOSES) in patients with upper rectal cancer

Factors

NOSES

Mini-Lapa

P value

Mean (n)

SD (%)

Mean (n)

SD (%)

Gender (F/M, n/%)

34/39

46.6/53.4

6/32

15.8/84.2

0.001

Age (mean ± SD, year)

60.3

11.8

64.8

10.3

0.050

BMI (< / ≥ 25)

59/14

80.8/19.2

29/9

76.3/23.7

0.578

CEA (−/ +)

63/10

86.3/13.7

20/18

52.6/47.4

 < 0.001

CA19-9 (−/ +)

66/7

90.4/9.6

27/11

71.1/28.9

0.009

Tumor location (mean ± sd, cm)

9.3

3.5

10.3

2.8

0.130

MTD (mean ± sd, mm)

14.3

6.7

17.1

9.5

0.072

RD (mean ± sd, mm)

27.3

6.8

31.3

10.4

0.068

MRL (< / ≥ 13.4)

35/38

47.9/52.1

7/31

18.4/81.6

0.002

ROD (< / ≥ 1.8)

62/11

84.9/15.1

17/21

44.7/55.3

 < 0.001

ROA (< / ≥ 2.1)

60/13

82.2/17.8

14/24

36.8/63.2

 < 0.001

Differentiation (G1 + G2/G3 + G4)

58/15

79.5/20.5

28/10

73.7/26.3

0.490

Neural invasion (−/ +)

61/12

83.6/16.4

27/11

71.1/28.9

0.123

Vascular invasion (−/ +)

54/19

74.0/26.0

31/7

81.6/18.4

0.369

Lymphatic invasion (−/ +)

53/20

72.6/27.4

21/17

55.3/44.7

0.066

LNC (mean ± SD)

13.8

4.6

15.6

5.0

0.051

PLNC (mean ± SD)

1.7

3.2

1.8

3.1

0.871

T stage (T1/2/3/4)

11/17/34/11

15.1/23.3/46.6/15.1

2/9/22/5

5.3/23.7/57.9/13.2

0.432

N stage (N0/1/2)

44/15/14

60.3/20.5/19.2

21/11/6

55.3/28.9/15.8

0.601

M stage (M0/1)

69/4

94.5/5.5

34/4

89.5/10.5

0.329

TNM stage (Stage I/II/III/IV)

21/21/27/4

28.8/28.8/37.0/5.5

7/14/13/4

18.4/36.8/34.2/10.5

0.473

  1. BMI, body mass index; MTD, maximum tumor cross-sectional diameter; RD, rectum diameter; MRL, mesorectum length; ROD, ratio of diameter; ROA, ratio of area